Track topics on Twitter Track topics that are important to you
WASHINGTON — Diopsys will introduce two new visual electrophysiology testing products at the American Society of Cataract and Refractive Surgery meeting.The Retina Plus is a carry-case-sized device ...
The Diopsys® Chromatic Flash Vision Screener is a simple-to-use and easy-to-integrate protocol within the Diopsys® ffERG / Full Field Electroretinography module. PINE BROOK, N.J. (PRWEB) Oct...
RETINA PLUS and multifocal electroretinography (mfERG) will offer eye care experts access to powerful new tools for understanding the health of the retina. PINE BROOK, N.J. (PRWEB) April 13, 2018 Dio...
Clinic-based pattern electroretinography (PERG) from Diopsys equips eye care specialists with actionable information for better, timelier clinical decision making. PINE BROOK, N.J. (PRWEB) May 08, 201...
Glaucoma is a common and potentially blinding disease. It is characterized by an optic nerve damage, a visual field defect and elevated intraocular pressure (IOP). The loss of retinal ner...
The purpose of this study is to establish electrophysiological benchmarks, using the Diopsys Visual Evoked Potential/ Pattern Electroretinogram (VEP/PERG) protocols of populations with Gla...
The aim of this study was to evaluate structural and functional improvement following intraocular pressure (IOP) reductions in patients with glaucoma using Spectral Domain Optical Coherenc...
We have published hundreds of Diopsys news stories on BioPortfolio along with dozens of Diopsys Clinical Trials and PubMed Articles about Diopsys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Diopsys Companies in our database. You can also find out about relevant Diopsys Drugs and Medications on this site too.